ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Why Is Clover Health (CLOV) Stock Soaring Today

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CLOV Cover Image

What Happened?

Shares of health insurance company Clover Health (NASDAQ: CLOV) jumped 6.6% in the afternoon session after strong first-quarter 2026 results from industry leader UnitedHealth Group (UNH) boosted sentiment across the health insurance sector. 

UnitedHealth reported impressive performance, with first-quarter consolidated revenues reaching $111.7 billion and earnings from operations of $9.0 billion. The company also signaled confidence in its future, expecting full-year 2026 adjusted net earnings to exceed $18.25 per share. When a major company like UnitedHealth posts such positive results, it often creates a positive ripple effect, lifting investor confidence in the entire industry. This suggests a healthy market environment, which likely contributed to the upward movement in shares of smaller peers like Clover Health.

Is now the time to buy Clover Health? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Clover Health’s shares are extremely volatile and have had 33 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 14 days ago when the stock gained 4.8% on the news that the government announced a surprise increase in payment rates for Medicare Advantage plans. 

This change raises the revenue that insurance companies receive per patient from federal funds without increasing their costs. This is projected to improve profit margins for major providers like UnitedHealth and Humana.

Clover Health is down 1% since the beginning of the year, and at $2.39 per share, it is trading 37.6% below its 52-week high of $3.82 from October 2025. Investors who bought $1,000 worth of Clover Health’s shares 5 years ago would now be looking at only $263.54.

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.91
+1.63 (0.66%)
AAPL  266.17
-6.88 (-2.52%)
AMD  284.49
+9.54 (3.47%)
BAC  53.48
-0.47 (-0.87%)
GOOG  330.47
-4.93 (-1.47%)
META  668.84
-2.07 (-0.31%)
MSFT  424.16
+6.09 (1.46%)
NVDA  199.88
-2.18 (-1.08%)
ORCL  181.17
+3.59 (2.02%)
TSLA  386.42
-6.08 (-1.55%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.